Placental clues: do progesterone receptors influence gestational diabetes?

NCT ID NCT07750431

Ongoing Knowledge-focused Sponsor: Samsun University Source: ClinicalTrials.gov ↗

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This study investigates whether certain progesterone receptors in the placenta are linked to gestational diabetes, a type of diabetes that develops during pregnancy. Researchers will compare placental tissue from women with gestational diabetes to tissue from healthy pregnant women to see if the levels of these receptors differ. The goal is to better understand the biological mechanisms behind the condition, which could inform future research.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If this study finds a link, it could point toward new ways to predict or manage gestational diabetes in the future.
What could go wrong: This is an observational study, so it cannot prove cause and effect. The findings may not lead to any treatment or prevention strategy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIAONL DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gestational diabetes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GESTATIAONL DIABETES MELLITUS

Contacts and locations

Locations

Samsun City Hospital

Samsun, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.